Our performance

Community investment

We are committed to meeting our responsibility as a global corporation to support the wider community, maximising the benefit of our investment for all stakeholders, through focused investment and by embracing current best practice.

In 2013, we spent a total of $1.12 billion (2012: $1.18 billion) on community investment sponsorships, partnerships and charitable donations worldwide, including our product donation and patient assistance programmes which make our medicines available free of charge or at reduced prices. Through our three patient assistance programmes in the US we donated products valued at an average wholesale price of over $1.05 billion (2012: $1.12 billion). We also donated products worth over $18 million, valued at average wholesale price, to charitable organisations Americares and Direct Relief International.

Our global community investment strategy focuses on two key areas, healthcare in the community and science in education.

In 2013, we continued to expand our Young Health Programme (YHP) country programme and have 18 programmes under way around the world. With over 480,000 young people directly reached with the skills and information they need to improve their health, we have exceeded our target of reaching a minimum of 300,000 young people by the end of 2013. This includes young people in communities across five continents. Over 4,500 of these young people have been trained to share this health information with their peers and with the community, and over 9,000 frontline health providers have completed training programmes in adolescent health.

We are also on track to meet our Clinton Global Initiative commitment to reach 500,000 young people by the end of 2015. As part of YHP, our work with Johns Hopkins Bloomberg School of Public Health (JHSPH) in 2013 included the publication of a special edition of the Journal of Adolescent Health. Phase 1 findings from the Wellbeing of Adolescents in Vulnerable Environments (WAVE) study being undertaken by JHSPH were also presented at the International Association of Adolescent Health World Congress, Istanbul in June 2013. Phase 2 of WAVE has been completed, with a final report due in 2014.

Our support for science education in the community takes a number of forms. For example, in 2011, we entered a three year partnership with Career Academies UK to support increased participation by 16 to 19-year-olds in Science, Technology, Engineering and Maths (STEM) subjects. The target that one-third of Career Academies have a STEM theme by the 2014/15 academic year, was exceeded in the 2013/14 academic year, with 54 Career Academies (35%) having a STEM theme. 

Disaster Relief

The British Red Cross continues to act as our global disaster relief partner, with the majority of disaster relief donations channelled through them. In response to the typhoon in the Philippines in November 2013, we donated £250,000 ($390,000) via the British Red Cross to the Philippines Disaster Appeal. Product donations with a wholesale average cost value of over $350,000 were also made to support the victims of the disaster.

Following the 2011 earthquake in Japan, we made a commitment of 100 million yen ($1,037,700) to Japanese charity Ashinaga, to build Sendai Rainbow House, a house for children orphaned by the earthquake. In accordance with agreed project milestones, in October 2013 we made a final donation to Ashinaga, of 25 million Japanese yen ($259,425), completing our commitment. Completion of Sendai Rainbow House is expected in early 2014.

Go back to...

Next section

Community investment

Backed by our Global Community Support Policy, our activities around the world are focused on bringing sustainable benefit.

Read more

Governance & management

Read about how we identify, prioritise & manage the issues relating to our business that affect our stakeholders.

Read more

Are you in the US?

AZ&me logo

Our AZ&me site in the US provides health information, resources and prescription savings guidance for the general public.

View website